BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 11444761)

  • 1. Pharmacology of rapid-onset antidepressant treatment strategies.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission.
    Haddjeri N; Blier P; de Montigny C
    J Affect Disord; 1998 Dec; 51(3):255-66. PubMed ID: 10333981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
    Béïque JC; Blier P; de Montigny C; Debonnel G
    Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible neurobiological mechanisms underlying faster onset of antidepressant action.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 4():7-11; discussion 37-40. PubMed ID: 11229789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats.
    Nguyen KQ; Tohyama Y; Watanabe A; Hasegawa S; Skelin I; Diksic M
    Neurochem Int; 2009; 54(3-4):161-71. PubMed ID: 19073228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirtazapine: clinical overview.
    Gorman JM
    J Clin Psychiatry; 1999; 60 Suppl 17():9-13; discussion 46-8. PubMed ID: 10446735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine.
    Haddjeri N; Blier P; de Montigny C
    Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():11-7. PubMed ID: 8930005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG
    J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.
    Millan MJ; Gobert A; Rivet JM; Adhumeau-Auclair A; Cussac D; Newman-Tancredi A; Dekeyne A; Nicolas JP; Lejeune F
    Eur J Neurosci; 2000 Mar; 12(3):1079-95. PubMed ID: 10762339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.
    Dawson LA; Nguyen HQ; Geiger A
    Neuropharmacology; 1999 Aug; 38(8):1153-63. PubMed ID: 10462128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus.
    Szabo ST; Blier P
    Neuropsychopharmacology; 2001 Dec; 25(6):845-57. PubMed ID: 11750178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term treatment with the alpha 2-adrenoceptor antagonist mirtazapine on 5-HT neurotransmission.
    Haddjeri N; Blier P; de Montigny C
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):20-9. PubMed ID: 9007838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain.
    Besson A; Haddjeri N; Blier P; de Montigny C
    Eur Neuropsychopharmacol; 2000 May; 10(3):177-88. PubMed ID: 10793320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.
    Blier P; Szabo ST
    J Clin Psychiatry; 2005; 66 Suppl 8():30-40. PubMed ID: 16336034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects--a possible opioid involvement in severe depression?
    Schreiber S; Bleich A; Pick CG
    J Mol Neurosci; 2002; 18(1-2):143-9. PubMed ID: 11931344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission.
    de Boer T
    Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():19-23. PubMed ID: 8930006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo.
    Arborelius L; Linnér L; Wallsten C; Ahlenius S; Svensson TH
    Psychopharmacology (Berl); 2000 Jul; 151(1):77-84. PubMed ID: 10958120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
    Gartside SE; Clifford EM; Cowen PJ; Sharp T
    Br J Pharmacol; 1999 May; 127(1):145-52. PubMed ID: 10369467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.